Berrino L - Search Results

1

Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study.

Scavone C, Sportiello L, Sullo MG, Ferrajolo C, Ruggiero R, Sessa M, Berrino PM, di Mauro G, Berrino L, Rossi F, Rafaniello C, Capuano A; BIO-Cam Group. Scavone C, et al. Among authors: berrino l, berrino pm. Front Pharmacol. 2017 Sep 6;8:607. doi: 10.3389/fphar.2017.00607. eCollection 2017. Front Pharmacol. 2017. PMID: 28932193 Free PMC article.

2

Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.

Calderaro V, Parrillo C, Giovane A, Greco R, Matera MG, Berrino L, Rossi F. Calderaro V, et al. Among authors: berrino l. J Pharmacol Exp Ther. 1992 Nov;263(2):579-87. J Pharmacol Exp Ther. 1992. PMID: 1331406

3

Effects of tetanus toxin, Salmonella typhimurium porin, and bacterial lipopolysaccharide on platelet aggregation.

Matera C, Falzarano C, Berrino L, Rossi F. Matera C, et al. Among authors: berrino l. J Med. 1992;23(5):327-38. J Med. 1992. PMID: 1335019

4

Pregnenolone sulfate increases the convulsant potency of N-methyl-D-aspartate in mice.

Maione S, Berrino L, Vitagliano S, Leyva J, Rossi F. Maione S, et al. Among authors: berrino l. Eur J Pharmacol. 1992 Sep 4;219(3):477-9. doi: 10.1016/0014-2999(92)90493-n. Eur J Pharmacol. 1992. PMID: 1425973

5

Central arrhythmogenic effects of N-methyl-D-aspartate (NMDA) in anesthetized rats: influence of the denervation of the carotid-sinus baroreceptors on the susceptibility to arrhythmias.

Berrino L, Cuparencu B, de Novellis V, Stella L, Magrella M, Rossi F. Berrino L, et al. Res Commun Chem Pathol Pharmacol. 1992 Nov;78(2):141-9. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1475526

6

Nitric oxide participates in the hypotensive effect induced by adenosine A2 subtype receptor stimulation.

Stella L, Berrino L, Filippelli A, de Novellis V, Rossi F. Stella L, et al. Among authors: berrino l. J Cardiovasc Pharmacol. 1995 Jun;25(6):1001-5. doi: 10.1097/00005344-199506000-00021. J Cardiovasc Pharmacol. 1995. PMID: 7564326

7

Relation between L-arginine-nitric oxide pathway and endothelin-1 effects in periaqueductal gray area of rats.

D'Amico M, Berrino L, Filippelli A, Maione S, Rossi F. D'Amico M, et al. Among authors: berrino l. J Cardiovasc Pharmacol. 1994 Dec;24(6):974-8. doi: 10.1097/00005344-199424060-00016. J Cardiovasc Pharmacol. 1994. PMID: 7898082

8

Involvement of periaqueductal gray area NMDA receptors in endothelin-induced behavioural effects.

Maione S, D'Amico M, Berrino L, Filippelli A, Leyva J, Rossi F. Maione S, et al. Among authors: berrino l. Eur J Pharmacol. 1993 Nov 30;250(1):209-12. doi: 10.1016/0014-2999(93)90647-z. Eur J Pharmacol. 1993. PMID: 7907022

9

Cardiotoxicity of doxorubicin: effects of drugs inhibiting the release of vasoactive substances.

Rossi F, Filippelli W, Russo S, Filippelli A, Berrino L. Rossi F, et al. Among authors: berrino l. Pharmacol Toxicol. 1994 Aug;75(2):99-107. doi: 10.1111/j.1600-0773.1994.tb00330.x. Pharmacol Toxicol. 1994. PMID: 7971744

10

Periaqueductal gray area and cardiovascular function.

Rossi F, Maione S, Berrino L. Rossi F, et al. Among authors: berrino l. Pharmacol Res. 1994 Jan-Feb;29(1):27-36. doi: 10.1016/1043-6618(94)80095-2. Pharmacol Res. 1994. PMID: 8202441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters